In a striking new study, the anti-obesity drug tirzepatide, known as Mounjaro and Zepbound, not only triggered significant ...

USA: A new study published in the Journal of Diabetes and Its Complications suggests that tirzepatide, a novel dual ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, ... semaglutide has also shown potential benefits for cardiovascular health, sleep apnea and kidney ...

In this trial, both drugs helped improve these health markers, but tirzepatide’s added benefits could make it the top choice for many people with obesity. Still, not every patient will need the ...

Find out what compounded tirzepatide is and how it compares ... A specialty pharmacy provides medications for complex health ... that the addition of vitamin B12 enhances overall treatment benefits.

Even modest weight loss can lead to important health benefits. Losing at least 5% of body weight cuts the risk of developing diabetes and meaningfully improves blood pressure and cholesterol.

A head-to-head trial found that tirzepatide led to significantly greater weight loss and waist reduction than semaglutide in adults with obesity but without diabetes. Over 72 weeks, tirzepatide ...

‘Staggering’ Uptake of Newer Glucose-Lowering and Weight-Loss Drugs. The study population included 1,830,876 adults with T2D prescribed any glucose-lowering medication between 2021 and 2023 ...

Citation: Tirzepatide produces clinically meaningful weight loss for at least 3 years in non-diabetic overweight adults: Trial (2025, April 14) retrieved 6 July 2025 from https://medicalxpress.com ...